RecruitingNot ApplicableNCT06353698

Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia

The Effect of Fasting Mimicking Diet With Chemotherapy on the Number of Blasts and Platelets and Quality of Life in Patients With Acute Lymphoid Leukemia and Acute Myeloid Leukemia

Sponsor

National Nutrition and Food Technology Institute

Enrollment

40 participants

Start Date

Jul 2, 2023

Study Type

INTERVENTIONAL

Conditions

Leukemia Fasting Mimicking Diet

Summary

The goal of this clinical trial is to investigate The effect of fasting mimicking diet with chemotherapy on the number of blasts and platelets and quality of life in patients with acute lymphoid leukemia and acute myeloid leukemia.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study explores whether a special "fasting-mimicking diet" — a low-calorie diet that tricks the body into a fasting state — can improve the effectiveness of chemotherapy in people newly diagnosed with acute leukemia. Researchers believe fasting may help make cancer cells more vulnerable to treatment. **You may be eligible if...** - You have recently been diagnosed with acute leukemia - You have been prescribed chemotherapy - Your body mass index (BMI) is greater than 18.5 (not underweight) - You are willing to cooperate with the dietary requirements **You may NOT be eligible if...** - You have diabetes - Your leukemia has spread to other organs - You decide to stop participating during the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTfasting mimicking diet

Fasting mimicking diet is limited calorie diet to enhance the effectiveness of chemotherapy

Locations(2)

Azita Hekmatdoost

Tehran, Middle East, Iran

Ehsan Hejazi

Tehran, Iran

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06353698

Related Trials

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT052379863 locations

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

NCT055363491 location

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

NCT06578247288 locations

Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

NCT030585881 location

A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia

NCT075567572 locations